norbadione A: RN given for (E,E)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 54679293 |
| SCHEMBL ID | 12766867 |
| MeSH ID | M0437799 |
| Synonym |
|---|
| 90295-68-4 |
| unii-8dh6bnl8ba |
| 8dh6bnl8ba , |
| naphthalenoid pulvinic acid derv. from pisolithus tinctorius fungus |
| nsc-605656 |
| NSC605656 , |
| norbadione a |
| SCHEMBL12766867 |
| Q15425764 |
| norbadion a |
| benzeneacetic acid, .alpha.,.alpha.-((8-hydroxy-2-oxo-2h-naphtho(1,8-bc)furan-4,6-diyl)bis(3-hydroxy-5-oxo-4-furanyl-2(5h)-ylidene))bis(4-hydroxy-, (.alpha.e,.alpha.e)- |
| benzeneacetic acid, .alpha.,.alpha.-((8-hydroxy-2-oxo-2h-naphtho(1,8-bc)furan-4,6-diyl)bis(3-hydroxy-5-oxo-4-furanyl-2(5h)-ylidene))bis(4-hydroxy-, (e,e)- |
| (.alpha.e,.alpha.e)-.alpha.,.alpha.-((8-hydroxy-2-oxo-2h-naphtho(1,8-bc)furan-4,6-diyl)bis(3-hydroxy-5-oxo-4-furanyl-2(5h)-ylidene))bis(4-hydroxybenzeneacetic acid) |
| DTXSID301045531 |
Norbadione A (NBA) is a pigment present in edible mushrooms. presumed to selectively complex Cs(+) cations. assumed to be involved in (137)Cs accumulation all over Europe during the Chernobyl nuclear accident.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Norbadione A (NBA) is a pigment present in edible mushrooms which is presumed to selectively complex Cs(+) cations. " | ( Complexation of Cs+, K+ and Na+ by norbadione A triggered by the release of a strong hydrogen bond: nature and stability of the complexes. Antheaume, C; Kuad, P; Maechling, C; Mioskowski, C; Schurhammer, R; Spiess, B; Wipff, G, 2009) | 2.07 |
| "Norbadione A (NbA) is a mushroom pigment, which is assumed to be involved in (137)Cs accumulation all over Europe during the Chernobyl nuclear accident. " | ( Norbadione a: kinetics and thermodynamics of cesium uptake in aqueous and alcoholic media. El Hage Chahine, JM; Ha-Duong, NT; Korovitch, A; Le Gall, T; Leray, I; Lion, C; Mallinger, A; Mulon, JB; Nadal, B; Souchon, V; Valeur, B, 2010) | 3.25 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.85) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||